Crossmark

Controversies in the use of next-generation imaging for evaluation and treatment decision-making in patients with prostate cancer after biochemical recurrence: views from a Spanish expert panel

Crossref DOI link: https://doi.org/10.1007/s12094-024-03833-6

Published Online: 2025-01-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maldonado, Xavier https://orcid.org/0000-0003-2045-4723
Boladeras, Anna

Gaya, José María

Muñoz, Jesús

Planas, Jacques

Sancho, Gemma

Suárez, José Francisco
Funding

Funding for this research was provided by:

Bayer Hispania S.L.
License Information

Text and Data Mining valid from 2025-01-02

Version of Record valid from 2025-01-02
More Information

Article History

Received: 15 September 2024

Accepted: 19 December 2024

First Online: 2 January 2025

Declarations

:

: The authors have no conflict interest to declare that are relevant to the content of this article.

: This article does not contain any studies with human participants or animals performed by any of the authors.

Document is current

Any future updates will be listed below